Study reveals those who microdosed psilocybin for 30 days showed greater improvements in mood, mental health, and psychomotor abilities than those who did not microdose. The findings have positive implications for the use of psychedelics to help treat mental health disorders.
Researchers say they have found no evidence LSD microdosing improves mood or cognitive function.
From microdosing to improve cognition, to treating a range of mental health disorders, researchers evaluate the rise in the use of psychedelics and their potential as medicines.
Those who microdose psychedelics report improved mood, greater focus, and increased creativity. A new study looks at the positive outcomes of microdosing and suggests others look at potential long-term negative consequences of using psychedelics.
While many people report microdosing is beneficial to their mental wellbeing, researchers say more research needs to be conducted to evaluate the psychological and health implications of taking low-dose psychedelics.
Microdosing, a growing trend where people take small doses for psychedelic drugs, is associated with improved mood, focus, and creativity. For some, microdosing may provide a possible alternative to SSRI antidepressants. However, researchers warn of some potential problems with microdosing, including negative side effects, psychological stigma, and exposure to elicit, black market products.
Research on rats suggests microdosing DMT may have beneficial effects for those suffering depression and anxiety, but also probable adverse changes in neuronal structures and metabolism.
A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.
A new study reports microdosing psychedelics may enhance creative problem solving without risk of hallucinations, or trips, associated with taking high doses of the substances.